Euda Health suspends $10 million at-the-market share offering ahead of termination of Chardan agreement

EUDA Health Holdings Limited

EUDA

0.00

Euda Health Holdings has suspended its at-the-market offering of up to USD 10 million in ordinary shares.
The company issued a termination notice for its equity distribution agreement with Chardan Capital Markets.
The termination is set to take effect on July 22, 2026.
It plans to file a prospectus supplement to reduce the remaining shares available under prior prospectus supplements to zero.
No shares have been sold under the program.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euda Health Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-028040), on June 10, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.